AbbVie (ABBV) 7-Part Filing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street rises on revived AI momentum as earnings season picks up
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $286.41 -0.12%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.4%
Revenue Growth %: +10.0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.4%
Revenue Growth %: +10.0%
Join SI Premium – FREE
AbbVie (NYSE: ABBV) 7-Part Filing
- https://www.sec.gov/Archives/edgar/data/1551152/000110465926019303/tm266774d3_fwp.htm
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA: Amgen Vectibix promotional video found false or misleading
- Alaska Airlines plans nonstop Anchorage-Tokyo Narita flights in 2027
- On Holding AG (ONON) call put ratio 1 call to 1.8 putsm share price down 2.4%
Create E-mail Alert Related Categories
General NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
